Matt Cross
Stock Analyst at Alliance Global Partners
(n/a)
# 4,425
Out of 4,433 analysts
1
Total ratings
n/a
Success rate
-49.6%
Average return
Main Sectors:
Top Industries:
1 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYRS Syros Pharmaceuticals | Maintains: Buy | $140 → $100 | $5.48 | +1,724.82% | 1 | May 17, 2022 |
Syros Pharmaceuticals
May 17, 2022
Maintains: Buy
Price Target: $140 → $100
Current: $5.48
Upside: +1,724.82%